Home > Riviste > Minerva Respiratory Medicine > Fascicoli precedenti > Minerva Respiratory Medicine 2021 September;60(3) > Minerva Respiratory Medicine 2021 September;60(3):96-9

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

ORIGINAL ARTICLE   

Minerva Respiratory Medicine 2021 September;60(3):96-9

DOI: 10.23736/S2784-8477.21.01936-2

Copyright © 2021 EDIZIONI MINERVA MEDICA

lingua: Inglese

The role of myofunctional therapy in the treatment of enuretic children with sleep-disordered breathing

Pietro FERRARA 1 , Diletta SAITTA 1, Giulia FRANCESCHINI 1, Martina VECCHIO 1, Chiara DE LISO 1, Daniela M. GRASSO 2, Francesca BALDO 2, Andrea IANNI 3, Maria P. VILLA 4

1 Unit of Pediatrics, Campus Bio-Medico University, Rome, Italy; 2 Institute of Pediatrics, Sacred Heart Catholic University, Rome, Italy; 3 Unit of Hygiene, Statistics and Public Health, Campus Bio-Medico University, Rome, Italy; 4 Department of Pediatrics, Sapienza University, Rome, Italy



BACKGROUND: The aim of this study was to evaluate if an effective and noninvasive treatment of sleep-disordered breathing may decrease the frequency of nocturnal enuresis in children presenting both the aforesaid clinical conditions.
METHODS: The study was carried out within our pediatric outpatient clinic in Campus Bio-Medico University Hospital of Rome, enrolling a total of 90 children, aged between 5 and 15 years, presenting nocturnal enuresis and sleep-disordered breathing. After clinical evaluation, children were randomized in two different treatment groups: group 1, desmopressin with or without oxybutynin, dietary and lifestyle recommendations and myofunctional therapy; group 2, desmopressin with or without oxybutynin, and dietary and lifestyle recommendations. All patients were treated for 3 months.
RESULTS: After 3 months of therapy and 3 months of follow-up, the response rate distribution was 85.7% for the group 1 and 56.2% for the group 2. The results were statistically significant (P<0.05). This study was conducted in accordance with the regulatory standards of Good Clinical Practice and the Declaration of Helsinki.
CONCLUSIONS: A higher response rate was achieved by the group treated with the combination of pharmacological and myofunctional therapy.


KEY WORDS: Enuresis; Myofunctional therapies; Sleep apnea syndromes

inizio pagina